|
|
|
Liver Diseases – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Liver Diseases – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Liver Diseases - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Liver Diseases,
|
read more...
|
$2,000.00
|
|
Ocular Inflammation – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Ocular Inflammation – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Ocular Inflammation - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Ocular Inflammation,
|
read more...
|
$2,000.00
|
|
Leg Ulcers – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Leg Ulcers – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Leg Ulcers - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Leg Ulcers,
|
read more...
|
$2,000.00
|
|
House Dust Mite Allergy – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
House Dust Mite Allergy – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'House Dust Mite Allergy - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic
|
read more...
|
$2,000.00
|
|
Oropharyngeal Cancer – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Oropharyngeal Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Oropharyngeal Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Oropharyngeal Cancer,
|
read more...
|
$2,000.00
|
|
Pulmonary Tuberculosis – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Pulmonary Tuberculosis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Pulmonary Tuberculosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Pulmonary Tuberculosis,
|
read more...
|
$2,000.00
|
|
Streptococcus Pneumoniae Infection – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Streptococcus Pneumoniae Infection – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Streptococcus Pneumoniae Infection - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for
|
read more...
|
$2,000.00
|
|
Muscle Atrophy – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Muscle Atrophy – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Muscle Atrophy - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Muscle Atrophy,
|
read more...
|
$2,000.00
|
|
Metastatic Ovarian Cancer – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Metastatic Ovarian Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Ovarian Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for
|
read more...
|
$2,000.00
|
|
Influenza B Infections – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Influenza B Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Influenza B Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for
|
read more...
|
$2,000.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Drug Discovery Reports
- Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer’s Disease
- Central Nervous System Disorder Drugs Markets in China
- Lymphoma Treatment Drugs Markets in China
- Anti-Tumor Drugs Markets in China
- Osteoporosis Treatment Drugs Markets in China
